Venous thromboembolism risk factor assessment and prophylaxis.

PubWeight™: 0.92‹?›

🔗 View Article (PMC 4487984)

Published in Phlebology on October 01, 2010

Authors

P K Henke1, C J Pannucci

Author Affiliations

1: University of Michigan Health System, 1500 East Medical Center Drive, Cardiovascular Center, SPC 5463, Ann Arbor, MI 48109-5867, USA. henke@umich.edu

Articles cited by this

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med (2008) 43.36

Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 16.17

Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation (2010) 9.18

Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet (2008) 9.10

Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med (2005) 7.90

D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review. Ann Intern Med (2004) 6.15

Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study. BMJ (2009) 4.99

Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood (2008) 4.06

Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med (2002) 3.91

Thrombosis risk assessment as a guide to quality patient care. Dis Mon (2005) 2.13

A systematic review of strategies to improve prophylaxis for venous thromboembolism in hospitals. Ann Surg (2005) 2.03

Epidemiology and risk factors for venous thrombosis. Semin Hematol (2007) 1.90

Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation. JAMA (2006) 1.72

A validation study of a retrospective venous thromboembolism risk scoring method. Ann Surg (2010) 1.59

Risk assessment as a guide for the prevention of the many faces of venous thromboembolism. Am J Surg (2010) 1.54

Risk factors and clinical impact of postoperative symptomatic venous thromboembolism. J Vasc Surg (2007) 1.47

Thromboembolic risk assessment and the efficacy of enoxaparin prophylaxis in excisional body contouring surgery. Plast Reconstr Surg (2008) 1.31

Call to action to prevent venous thromboembolism. J Vasc Surg (2009) 1.17

D-dimer, P-selectin, and microparticles: novel markers to predict deep venous thrombosis. A pilot study. Thromb Haemost (2005) 1.17

Venous thromboembolism in cancer patients undergoing major surgery. Ann Surg Oncol (2008) 1.07

Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison. J Thromb Haemost (2007) 1.02

The rate of bleeding complications after pharmacologic deep venous thrombosis prophylaxis: a systematic review of 33 randomized controlled trials. Arch Surg (2006) 0.94

Changes in the levels of soluble adhesion molecules and coagulation factors in patients with deep vein thrombosis. Thromb Haemost (1999) 0.91

Risk factors associated with venous thromboembolic events in patients with malignancy. Blood Coagul Fibrinolysis (2006) 0.87

Proximate versus nonproximate risk factor associated primary deep venous thrombosis: clinical spectrum and outcomes. J Vasc Surg (2007) 0.84

The significant negative impact of in-hospital venous thromboembolism after cardiovascular procedures. Ann Vasc Surg (2007) 0.79

Articles by these authors

Use of gracilis muscle as a "walking" flap for repair of a rectovaginal fistula. J Plast Reconstr Aesthet Surg (2013) 0.80